Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Sep 4;14(9):e0221771.
doi: 10.1371/journal.pone.0221771. eCollection 2019.

Prevalence of extended-spectrum beta-lactamase producing bacteria from animal origin: A systematic review and meta-analysis report from India

Affiliations
Meta-Analysis

Prevalence of extended-spectrum beta-lactamase producing bacteria from animal origin: A systematic review and meta-analysis report from India

Suresh P Kuralayanapalya et al. PLoS One. .

Abstract

Antimicrobial resistance (AMR) due to the emergence and spread of extended-spectrum beta-lactamase (ESBL) producing bacteria are becoming a serious global public health concern. This article aims to assess the overall prevalence of ESBLs among animals in India, with year-wise, zone-wise and species-wise stratification. Systematic search from PubMed, Google Scholar and J-Gate Plus was carried out and 24 eligible articles from 2013-2019 in India were retrieved. The R Open source Scripting software was used to perform statistical analysis. The overall prevalence of ESBLs among animals in India was 9%. The pooled prevalence of ESBLs in animals were 26, 11, 6 and 8% for north, east, south and central zones, respectively. The reported prevalence of ESBLs in animals were 12, 5, 8, 8, 12, 13 and 33% were reported for the years 2013, 2014, 2015, 2016, 2017, 2018, 2019 respectively. The species-wise stratified results showed a predominance of ESBL producing Klebsiella pneumoniae strains (11%) when compared to Escherichia coli and Pseudomonas spp. which were 7% and 5%, respectively. The prevalence data generated could be utilized in infection control and in antibiotic use management decisions for developing appropriate intervention strategies.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Figures

Fig 1
Fig 1. The flow diagram of study selection process.
Fig 2
Fig 2. Forest plot of ESBL prevalence in India from 2013–2019.
Fig 3
Fig 3
Forest plots of ESBL prevalence in (a) 2013; (b) 2014; (c) 2015; (d) 2016; (e) 2017; (f) 2018; and (g) 2019.
Fig 4
Fig 4
Forest plots of ESBL prevalence in (a) north-zone; (b) east-zone; (c) south-zone; and (d) central-zone.
Fig 5
Fig 5. Forest plot of E. coli producing ESBL prevalence.
Fig 6
Fig 6. Forest plot of K. pneumonia producing ESBL prevalence.
Fig 7
Fig 7. Forest plot of Pseudomonas spp. producing ESBL prevalence.

Similar articles

Cited by

References

    1. WHO-Ministry of health and family welfare: Antimicrobial resistance and its containment in India. World Health Organization; 2016. [Online at: http://www.searo.who.int/india/topics/antimicrobial_resistance/amr_conta...]
    1. Sarojamma V, Ramakrishna V. Prevalence of ESBL-producing Klebsiella pneumoniae isolates in tertiary care hospital. ISRN Microbiol. 2011;2011:318348 10.5402/2011/318348 - DOI - PMC - PubMed
    1. Hawkey PM. Prevalence and clonality of extended‐spectrum β‐lactamases in Asia. Clin Microbiol Infect. 2008;14:159–65. 10.1111/j.1469-0691.2007.01855.x - DOI - PubMed
    1. Ibrahim DR, Dodd CE, Stekel DJ, Ramsden SJ, Hobman JL. Multidrug resistant, extended spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from a dairy farm. FEMS Microbiol Ecol. 2016;92:fiw013 10.1093/femsec/fiw013 - DOI - PubMed
    1. Segar L, Kumar S, Joseph NM, Sivaraman U. Prevalence of extended spectrum beta-lactamases among Enterobacteriaceae and their anti-biogram pattern from various clinical samples. Asian J Pharma Clin. Res 2015;8(5):237–40.

Substances